{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T01:05:07Z","timestamp":1783991107106,"version":"3.55.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000},"content-version":"vor","delay-in-days":56,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82270684"],"award-info":[{"award-number":["82270684"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LTGD24H160002"],"award-info":[{"award-number":["LTGD24H160002"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-08279-8","type":"journal-article","created":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T10:14:01Z","timestamp":1779185641000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The STK33\/mTORC1\/S6K1\/HIF-1\u03b1 signalling axis drives glycolysis and progression in pancreatic neuroendocrine tumours"],"prefix":"10.1186","volume":"24","author":[{"given":"Bo","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Canyang","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenzhen","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4153-3546","authenticated-orcid":false,"given":"Sheng","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,19]]},"reference":[{"issue":"19","key":"8279_CR1","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.3748\/wjg.v26.i19.2305","volume":"26","author":"ZY Ma","year":"2020","unstructured":"Ma ZY, Gong YF, Zhuang HK, Zhou ZX, Huang SZ, Zou YP, et al. Pancreatic neuroendocrine tumors: A review of serum biomarkers, staging, and management. World J Gastroenterol. 2020;26(19):2305\u201322.","journal-title":"World J Gastroenterol"},{"issue":"2","key":"8279_CR2","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s00428-021-03211-5","volume":"480","author":"B Konukiewitz","year":"2022","unstructured":"Konukiewitz B, Jesinghaus M, Kasajima A, Kl\u00f6ppel G. Neuroendocrine neoplasms of the pancreas: diagnosis and pitfalls. Virchows Arch. 2022;480(2):247\u201357.","journal-title":"Virchows Arch"},{"issue":"8","key":"8279_CR3","doi-asserted-by":"publisher","first-page":"djv123","DOI":"10.1093\/jnci\/djv123","volume":"107","author":"RA Fran\u00e7ois","year":"2015","unstructured":"Fran\u00e7ois RA, Maeng K, Nawab A, Kaye FJ, Hochwald SN, Zajac-Kaye M. Targeting Focal Adhesion Kinase and Resistance to mTOR Inhibition in Pancreatic Neuroendocrine Tumors. J Natl Cancer Inst. 2015;107(8):djv123.","journal-title":"J Natl Cancer Inst"},{"issue":"19","key":"8279_CR4","doi-asserted-by":"publisher","first-page":"4949","DOI":"10.3390\/ijms20194949","volume":"20","author":"J Pozas","year":"2019","unstructured":"Pozas J, San Rom\u00e1n M, Alonso-Gordoa T, Pozas M, Caracuel L, Carrato A, et al. Targeting Angiogenesis in Pancreatic Neuroendocrine Tumors: Resistance Mechanisms. Int J Mol Sci. 2019;20(19):4949.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"8279_CR5","doi-asserted-by":"publisher","first-page":"100364","DOI":"10.1016\/j.esmoop.2021.100364","volume":"7","author":"T Al-Toubah","year":"2022","unstructured":"Al-Toubah T, Halfdanarson T, Gile J, Morse B, Sommerer K, Strosberg J. Efficacy of ipilimumab and nivolumab in patients with high-grade neuroendocrine neoplasms. ESMO Open. 2022;7(1):100364.","journal-title":"ESMO Open"},{"issue":"5","key":"8279_CR6","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1097\/PAS.0000000000000408","volume":"39","author":"O Basturk","year":"2015","unstructured":"Basturk O, Yang Z, Tang LH, Hruban RH, Adsay V, McCall CM, et al. The high-grade (WHO G3) pancreatic neuroendocrine tumor category is morphologically and biologically heterogenous and includes both well differentiated and poorly differentiated neoplasms. Am J Surg Pathol. 2015;39(5):683\u201390.","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"8279_CR7","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.cell.2008.08.021","volume":"134","author":"PP Hsu","year":"2008","unstructured":"Hsu PP, Sabatini DM. Cancer cell metabolism: Warburg and beyond. Cell. 2008;134(5):703\u20137.","journal-title":"Cell"},{"issue":"8","key":"8279_CR8","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1158\/0008-5472.CAN-14-1428","volume":"75","author":"M Robertson-Tessi","year":"2015","unstructured":"Robertson-Tessi M, Gillies RJ, Gatenby RA, Anderson AR. Impact of metabolic heterogeneity on tumor growth, invasion, and treatment outcomes. Cancer Res. 2015;75(8):1567\u201379.","journal-title":"Cancer Res"},{"issue":"51","key":"8279_CR9","doi-asserted-by":"publisher","first-page":"32529","DOI":"10.1074\/jbc.271.51.32529","volume":"271","author":"GL Semenza","year":"1996","unstructured":"Semenza GL, Jiang BH, Leung SW, Passantino R, Concordet JP, Maire P, et al. Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1. J Biol Chem. 1996;271(51):32529\u201337.","journal-title":"J Biol Chem"},{"issue":"1","key":"8279_CR10","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1053\/j.gastro.2017.03.008","volume":"153","author":"SH Jiang","year":"2017","unstructured":"Jiang SH, Li J, Dong FY, Yang JY, Liu DJ, Yang XM, et al. Increased Serotonin Signaling Contributes to the Warburg Effect in Pancreatic Tumor Cells Under Metabolic Stress and Promotes Growth of Pancreatic Tumors in Mice. Gastroenterology. 2017;153(1):277\u2013e29119.","journal-title":"Gastroenterology"},{"issue":"2","key":"8279_CR11","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1007\/s00259-014-2906-4","volume":"42","author":"R Kashyap","year":"2015","unstructured":"Kashyap R, Hofman MS, Michael M, Kong G, Akhurst T, Eu P, et al. Favourable outcomes of (177)Lu-octreotate peptide receptor chemoradionuclide therapy in patients with FDG-avid neuroendocrine tumours. Eur J Nucl Med Mol Imaging. 2015;42(2):176\u201385.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"5","key":"8279_CR12","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/j.cell.2009.03.017","volume":"137","author":"C Scholl","year":"2009","unstructured":"Scholl C, Fr\u00f6hling S, Dunn IF, Schinzel AC, Barbie DA, Kim SY, et al. Synthetic lethal interaction between oncogenic KRAS dependency and STK33 suppression in human cancer cells. Cell. 2009;137(5):821\u201334.","journal-title":"Cell"},{"issue":"1","key":"8279_CR13","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1136\/gutjnl-2014-307545","volume":"65","author":"T Yang","year":"2016","unstructured":"Yang T, Song B, Zhang J, Yang GS, Zhang H, Yu WF, et al. STK33 promotes hepatocellular carcinoma through binding to c-Myc. Gut. 2016;65(1):124\u201333.","journal-title":"Gut"},{"issue":"3\u20134","key":"8279_CR14","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1159\/000501829","volume":"110","author":"B Zhou","year":"2020","unstructured":"Zhou B, Xiang J, Zhan C, Liu J, Yan S. STK33 Promotes the Growth and Progression of Human Pancreatic Neuroendocrine Tumour via Activation of the PI3K\/AKT\/mTOR Pathway. Neuroendocrinology. 2020;110(3\u20134):307\u201320.","journal-title":"Neuroendocrinology"},{"issue":"1","key":"8279_CR15","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1038\/s41598-017-01729-w","volume":"7","author":"X Zhou","year":"2017","unstructured":"Zhou X, Liu W, Hu X, Dorrance A, Garzon R, Houghton PJ, et al. Regulation of CHK1 by mTOR contributes to the evasion of DNA damage barrier of cancer cells. Sci Rep. 2017;7(1):1535.","journal-title":"Sci Rep"},{"issue":"10","key":"8279_CR16","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1038\/nrc1187","volume":"3","author":"GL Semenza","year":"2003","unstructured":"Semenza GL. Targeting HIF-1 for cancer therapy. Nat Rev Cancer. 2003;3(10):721\u201332.","journal-title":"Nat Rev Cancer"},{"key":"8279_CR17","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.canlet.2020.12.020","volume":"502","author":"F Paredes","year":"2021","unstructured":"Paredes F, Williams HC, San Martin A. Metabolic adaptation in hypoxia and cancer. Cancer Lett. 2021;502:133\u201342.","journal-title":"Cancer Lett"},{"key":"8279_CR18","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.cellsig.2018.04.002","volume":"48","author":"Q Tran","year":"2018","unstructured":"Tran Q, Jung JH, Park J, Lee H, Hong Y, Cho H, et al. S6 kinase 1 plays a key role in mitochondrial morphology and cellular energy flow. Cell Signal. 2018;48:13\u201324.","journal-title":"Cell Signal"},{"issue":"1","key":"8279_CR19","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1038\/s41467-021-27944-8","volume":"13","author":"Y Yang","year":"2022","unstructured":"Yang Y, Lu H, Chen C, Lyu Y, Cole RN, Semenza GL. HIF-1 Interacts with TRIM28 and DNA-PK to release paused RNA polymerase II and activate target gene transcription in response to hypoxia. Nat Commun. 2022;13(1):316.","journal-title":"Nat Commun"},{"issue":"23","key":"8279_CR20","doi-asserted-by":"publisher","first-page":"e2300898","DOI":"10.1002\/advs.202300898","volume":"10","author":"Q Yang","year":"2023","unstructured":"Yang Q, Lei X, He J, Peng Y, Zhang Y, Ling R, et al. N4-Acetylcytidine Drives Glycolysis Addiction in Gastric Cancer via NAT10\/SEPT9\/HIF-1\u03b1 Positive Feedback Loop. Adv Sci (Weinh). 2023;10(23):e2300898.","journal-title":"Adv Sci (Weinh)"},{"issue":"7","key":"8279_CR21","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1080\/09553002.2019.1589653","volume":"95","author":"P Vaupel","year":"2019","unstructured":"Vaupel P, Schmidberger H, Mayer A. The Warburg effect: essential part of metabolic reprogramming and central contributor to cancer progression. Int J Radiat Biol. 2019;95(7):912\u20139.","journal-title":"Int J Radiat Biol"},{"issue":"4","key":"8279_CR22","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.molcel.2020.12.012","volume":"81","author":"A Luengo","year":"2021","unstructured":"Luengo A, Li Z, Gui DY, Sullivan LB, Zagorulya M, Do BT, et al. Increased demand for NAD+ relative to ATP drives aerobic glycolysis. Mol Cell. 2021;81(4):691\u2013e7076.","journal-title":"Mol Cell"},{"issue":"6","key":"8279_CR23","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1113\/JP278810","volume":"599","author":"P Vaupel","year":"2021","unstructured":"Vaupel P, Multhoff G. Revisiting the Warburg effect: historical dogma versus current understanding. J Physiol. 2021;599(6):1745\u201357.","journal-title":"J Physiol"},{"key":"8279_CR24","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1146\/annurev-cellbio-092910-154237","volume":"27","author":"SY Lunt","year":"2011","unstructured":"Lunt SY, Vander Heiden MG. Aerobic glycolysis: meeting the metabolic requirements of cell proliferation. Annu Rev Cell Dev Biol. 2011;27:441\u201364.","journal-title":"Annu Rev Cell Dev Biol"},{"issue":"1","key":"8279_CR25","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1186\/s13046-020-01765-x","volume":"39","author":"L Cao","year":"2020","unstructured":"Cao L, Wu J, Qu X, Sheng J, Cui M, Liu S, et al. Glycometabolic rearrangements\u2013aerobic glycolysis in pancreatic cancer: causes, characteristics and clinical applications. J Exp Clin Cancer Res. 2020;39(1):267.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"8279_CR26","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3390\/cancers10010005","volume":"10","author":"E Rad","year":"2018","unstructured":"Rad E, Murray JT, Tee AR. Oncogenic Signalling through Mechanistic Target of Rapamycin (mTOR): A Driver of Metabolic Transformation and Cancer Progression. Cancers (Basel). 2018;10(1):5.","journal-title":"Cancers (Basel)"},{"issue":"5","key":"8279_CR27","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1530\/REP-15-0523","volume":"151","author":"J G\u00fcrke","year":"2016","unstructured":"G\u00fcrke J, Schindler M, Pendzialek SM, Thieme R, Grybel KJ, Heller R, et al. Maternal diabetes promotes mTORC1 downstream signalling in rabbit preimplantation embryos. Reproduction. 2016;151(5):465\u201376.","journal-title":"Reproduction"},{"issue":"5","key":"8279_CR28","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1007\/s40618-023-02221-1","volume":"47","author":"E Vitali","year":"2024","unstructured":"Vitali E, Valente G, Panzardi A, Laffi A, Zerbi A, Uccella S, et al. Pancreatic neuroendocrine tumor progression and resistance to everolimus: the crucial role of NF-kB and STAT3 interplay. J Endocrinol Invest. 2024;47(5):1101\u201317.","journal-title":"J Endocrinol Invest"},{"issue":"12","key":"8279_CR29","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1158\/2159-8290.CD-20-0844","volume":"10","author":"SM Fendt","year":"2020","unstructured":"Fendt SM, Frezza C, Erez A. Targeting Metabolic Plasticity and Flexibility Dynamics for Cancer Therapy. Cancer Discov. 2020;10(12):1797\u2013807.","journal-title":"Cancer Discov"},{"key":"8279_CR30","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.molmet.2019.08.021","volume":"33","author":"P Kreuzaler","year":"2020","unstructured":"Kreuzaler P, Panina Y, Segal J, Yuneva M. Adapt and conquer: Metabolic flexibility in cancer growth, invasion and evasion. Mol Metab. 2020;33:83\u2013101.","journal-title":"Mol Metab"},{"issue":"9","key":"8279_CR31","doi-asserted-by":"publisher","first-page":"3664","DOI":"10.1172\/JCI67230","volume":"123","author":"GL Semenza","year":"2013","unstructured":"Semenza GL. HIF-1 mediates metabolic responses to intratumoral hypoxia and oncogenic mutations. J Clin Invest. 2013;123(9):3664\u201371.","journal-title":"J Clin Invest"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08279-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08279-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08279-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:10:34Z","timestamp":1783987834000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-08279-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,19]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8279"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-08279-8","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,19]]},"assertion":[{"value":"27 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Our study was approved by the Ethics Review Committee of the Second Affiliated Hospital of Zhejiang University School of Medicine. The approval included permission to access the raw data from the hospital medical records. Written informed consent was obtained from all the subjects included in our study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"898"}}